To define the roles of circadian rhythmicity (intrinsic effects of time of day independent of the sleep or wake condition) and sleep (intrinsic effects of the sleep condition, irrespective of the time of day) on the 24-h variation in glucose tolerance, eight normal men were studied during constant glucose infusion for a total of 53 h. The period of study included 8 h of nocturnal sleep, 28 h of continuous wakefulness, and 8 h of daytime sleep. Blood samples for the measurement of glucose, insulin, C-peptide, cortisol, and growth hormone were collected at 20-min intervals throughout the entire study. Insulin secretion rates were derived from C-peptide levels by deconvolution. Sleep was polygraphically monitored. During nocturnal sleep, levels of glucose and insulin secretion increased by 31 +/-5% and 60 +/-11%, respectively, and returned to baseline in the morning. During sleep deprivation, glucose levels and insulin secretion rose again to reach a maximum at a time corresponding to the beginning of the habitual sleep period. The magnitude of the rise above morning levels averaged 17 +/-5% for glucose and 49 +/-8% for calculated insulin secretion. Serum insulin levels did not parallel the circadian variation in insulin secretion, indicating the existence of an approximate 40% increase in insulin clearance during the night. 
Introduction
In normal man, glucose tolerance varies with the time of day. Plasma glucose responses to oral glucose, intravenous glucose, or meals are markedly higher in the evening than in the morning (1) (2) (3) . Diminished insulin sensitivity and decreased insulin secretion are both involved in causing reduced glucose tolerance later in the day (2, 4, 5) . Using experimental protocols involving intravenous glucose infusion at a constant rate for 24-30 hours, we have recently shown that glucose tolerance deteriorates as the evening progresses, reaching a minimum around the middle of the night (6, 7) . This diurnal variation was not caused by changes in activity level since it persisted during continuous bed rest (7) . Fluctuations in circulating levels of insulin or in insulin secretion rates did not consistently parallel the pattern of glucose changes. Since glucose concentrations began to increase in the late afternoon or early evening, well before bedtime, and continued to rise until approximately the middle ofthe night, both sleep-independent effects, reflecting circadian rhythmicity, and sleep-dependent effects could be involved in producing the overall 24-h pattern.
The purpose of this study was to define the respective roles of circadian rhythmicity (intrinsic effects of time of day independent of the sleep or wake condition) and sleep (intrinsic effects ofsleep per se irrespective ofthe time ofday) in the 24-h variation of glucose tolerance. To differentiate between the effects of circadian rhythmicity and those of sleep, eight normal men were subjected to a 12-h delay of their sleep period. The rationale behind this experimental design was to allow the effects of time of day to be observed in the absence of sleep and the effects of sleep to be observed at an abnormal circadian time. Glucose was infused at a constant rate for 57 h to avoid confounding effects of prolonged fasting or meal ingestion. Blood samples were collected at 20-min intervals for the last 53 h of the infusion. Sleep was polygraphically monitored. In addition to measurements of glucose, insulin, and C-peptide, the levels of cortisol, a counterregulatory hormone which is a robust marker ofcircadian rhythmicity, and those ofgrowth hormone (GH)', a counterregulatory hormone profoundly modulated by sleep, were determined on each blood sample. Insulin secretion rates (ISR) were derived from plasma C-peptide levels by deconvolution.
Methods
Subjects. Studies were performed in eight healthy men, aged 22-27 yr. Mean±SEM body weight and body mass index were respectively 72±2 kg and 22.7±0.7 kg/m2. None ofthe subjects had a history ofendocrine or psychiatric disorder. They were nonsmokers who were not taking any drugs. Shift workers or subjects who had travelled across time zones within 60 d before the study were excluded. All potential volunteers answered a detailed questionnaire concerning their daily routines, 1 . Abbreviations used in this paper: DS For one week before the study, the subjects complied with a standardized sleep schedule (2300-0700). To become habituated to the study conditions, the subjects slept in the sleep laboratory from 2300-0700 on the two days before the start ofthe study. On the first night, the electrodes for polygraphic sleep recording were attached but there was no actual recording. On the next night, sleep was polygraphically monitored and an i.v. infusion ofsaline was given to simulate the experimental condition on the following day.
On the day of the study, the subjects ate breakfast at 0800 and did not consume additional calories by mouth until the end of the study. They were free to drink water and diet decaffeinated beverages. At 1400, an infusion of 10% dextrose was started at a constant rate of 5 g/kg per 24 h and was maintained for 57 h. At 1600, a catheter for blood sampling was placed in the contralateral arm. Blood sampling at 20-min intervals started at 1800 and continued for the next 53 h. The i.v. line was kept patent by a slow drip of heparinized saline. The 4-h delay between the start ofglucose infusion and the start ofblood collection allowed glucose levels to equilibrate after the transient rise which accompanies the beginning of exogenous infusion (6). The 2-h delay between insertion of the sampling catheter and beginning of sample collection ensured that stress effects related to venipuncture had subsided. During the first night, the subjects slept in total darkness from 2300-0700 and sleep was polygraphically monitored. During sleep times, the catheter was connected to a plastic tubing (length 250 cm, dead space 2 ml) extending to the adjacent room through a hole in the wall so that sampling could continue without disturbing the subject. Sleep was interrupted at 0700 and the subjects remained awake for the next 28 h, i.e., until 1100 the next morning. Naps were not allowed. Light intensity was 100-200 lux throughout the periods ofwakefulness. The subjects remained seated in a comfortable armchair, watched television, read, played board games, and engaged in conversation with staff and visitors. They were allowed to use the bathroom, which was located within 15 ft of the armchair, but otherwise remained seated throughout the waking portions of the study. At 1100, i.e., 12 h later than the usual bedtime of 2300, the subjects went to sleep in complete darkness for an 8-h period. Sleep was polygraphically monitored. Procedures for blood sampling were as during sleep at normal hours. After awakening, blood sampling continued until 2300 when the glucose infusion was tapered off and the subjects were fed and discharged.
Assays. Glucose, C-peptide, insulin, GH, and cortisol were measured in duplicate on each blood sample. For each hormone, all samples from the same subject were analyzed in the same assay.
Plasma glucose was measured using an automatic analyzer (Model 23A; Yellow Springs Instrument Co., Yellow Springs, OH) with a coefficient of variation of < 2%. Plasma C-peptide levels were assayed as described previously (8) . The lower limit of the assay is 20 pmol/liter and the intraassay coefficient of variation averaged 6%. Serum insulin concentrations were determined by a double antibody technique with a lower level of sensitivity of 20 pmol/liter and an average intraassay coefficient ofvariation of6% (9) . GH levels were measured by a modification of a previously described RIA with a lower level ofsensitivity of 0.4 ag/liter (10) . The mean intraassay coefficient of variation is 14% in the range 0.4-2.0 ag/liter, 9% in the range 3-4,4g/liter, and 5% above 5 Ag/liter. Plasma cortisol was determined by radioimmunoassay (Diagnostic Products Corp., Los Angeles, CA). The lower limit ofsensitivity of this assay is 15 nmol/liter and the intraassay coefficient of variation averages 5%.
Determination ofinsulin secretory rates. Each subject participated in a separate outpatient study designed to determine his individual parameters of C-peptide disappearance kinetics (11 Analysis ofthe glucose, insulin, ISR, and cortisolprofiles. To quantify the long-term (e.g., diurnal) changes in glucose, insulin, ISR, and cortisol independently ofthe more rapid, pulsatile variations which are known to affect these variables (6, 14, 15) , a smooth best-fit curve was calculated for each individual profile using the robust, nonlinear regression procedure proposed by Cleveland (16) with a window of 6 h. With this window width, temporal changes which take place over time intervals of 6 h or more are quantitatively characterized while the contribution of more rapid variations is minimized. In the case of ISR, the contribution of the pulsatile variations to the overall temporal pattern was amplified due to the deconvolution procedure and the Cleveland regression method tended to systematically underestimate the magnitude of the long-term changes. Therefore, another procedure, based on repeated periodogram calculations (17) , was used to obtain a smooth best-fit curve. The nadirs and acrophases were defined, respectively, as the times of occurrence of minima and maxima in the best-fit curve. The value of a nadir (acrophase) was defined as the level of the best-fit curve at the nadir (acrophase). The increment associated with an acrophase was defined as the difference between the value of the acrophase and the value of the preceding nadir and was expressed either in measurement units (i.e., concentration or secretion rate) or as a percentage ofthe value ofthe preceding nadir (i.e., percent increase over preceding nadir).
Analysis ofthe GHprofiles. Because GH secretion normally occurs as a series of pulses superimposed over basal levels which are around the detection limit of most available assays (15) , the calculation of a smooth regression curve as performed for the other profiles is not applicable. Instead, each GH profile was analyzed using a modification of ULTRA, a computer program for pulse detection and quantification (18) . The threshold for significance of a pulse was set at three times the intraassay coefficient of variation in the relevant range of concentration. For each significant pulse, the amount ofGH secreted during both the ascending and declining limb of the pulse was estimated by integrating the equation dC/dt = S -kC, describing the instantaneous changes of the plasma concentration C resulting from secretion at rate Sand disappearance at a rate kC, where k is related to the half-life t/2 of the hormone through k = In 2/t,/2 (19 (Fig. 2) . This lack of parallelism between the profiles ofinsulin secretion and peripheral insulin concentrations during sleep deprivation reflected a circadian variation in insulin clearance, with clearance rates 30-40% higher during the first half ofthe habitual sleep period (2300-0300; 1.57±0.20 liter/min) than in the morning (0800-1 100; 1 Table II ). The cortisol profile of subject 5 is shown, as an example, in Fig. 1 and the mean cortisol profile for the group of eight subjects is illustrated in Fig. 2 . The nocturnal rise of cortisol started 1-2 h after sleep onset when sleep occurred at its normal time, and a morning maximum was observed within 1 h after morning awakening. Cortisol levels then declined throughout the day to reach a late evening nadir before the usual bedtime. Despite the absence of sleep, and the persistence of constant conditions of light and activity, cortisol levels rose again during the night and reached a maximum at approximately the same clock time as after the night with normal sleep. Table II gives (Table II) .
The profile of plasma GH concentrations observed in subject 5 during the 53-h study period is shown in Fig. 1 and the mean GH profiles for the group are illustrated in Fig. 2 . Variations in GH levels consisted of a series ofpulses occurring over stable baseline levels which were around the sensitivity of the assay. These GH profiles observed during constant glucose infusion were similar in every respect to previously reported profiles of GH secretion in healthy nonobese male adults studied during normal feeding conditions (15) . During the baseline night, significant GH pulses occurred during the hour preceding sleep onset in five ofthe eight subjects, and after sleep onset in all subjects. Comparisons of nocturnal GH secretion in the presence and in the absence of sleep were therefore based on the time interval 2200-0200. In the absence of sleep, significant pulses ofGH were detected between 2200 and 0200 in five of the eight subjects. However, these nocturnal GH pulses which occurred during wakefulness were of smaller amplitude than those observed during normal sleep. As indicated in Table   Table II After nocturnal sleep onset, levels of plasma glucose, insulin secretion, and plasma insulin (not shown) rose significantly above presleep values. These sleep-associated rises tended to be more pronounced when sleep onset occurred during the daytime, but the differences failed to reach significance. Before daytime sleep, presleep glucose and ISR levels tended to be lower than before nighttime sleep (P = 0.10 for glucose, P = 0.07 for ISR) and maximum levels after daytime sleep onset were observed within 2-3 h, in contrast to 3-4 h for nocturnal sleep onset (Table I, Fig. 3) .
Before nocturnal sleep, cortisol levels were low and were not significantly affected by sleep onset. However, after onset of sleep in the late morning, a marked inhibition of cortisol secretion was apparent, with a drop in mean cortisol level averaging 48.5±10.9% (Fig. 3) . As expected, sleep onset reproducibly stimulated GH secretion and a significant GH pulse started within 20 min after sleep onset in all subjects when sleep occurred at the normal nighttime and in seven of the eight subjects when sleep occurred in the morning. As Relationships between patterns ofglucose and ISR andpatterns ofcortisol and GH (Figs. 4-6) . Correlation matrices for all quantitative parameters characterizing the circadian and sleeprelated changes in glucose levels, ISR, cortisol concentrations, and GH secretion were calculated to identify significant associations between patterns ofglucose and/or ISR, on the one hand, and patterns of counterregulatory hormone secretion, on the other hand. Multiple regression analyses were performed wherever appropriate, but in no case resulted in the identification of more than one significant independent variable. These analyses were conducted separately for the period of sleep deprivation and for the periods of nocturnal and daytime sleep.
During the period ofsleep deprivation, there were no significant correlations between parameters quantifying GH secretion and parameters quantifying the nocturnal rises of glucose and ISR. Examination ofthe mean profiles of ISR and cortisol (Fig. 4) suggested the existence of an inverse relationship between temporal changes in pancreatic insulin secretion and circulating cortisol levels. Indeed, ISR was minimal in the early morning, when cortisol levels were at their peak, and increased throughout the day, while cortisol concentrations continuously declined. The nadir of cortisol generally preceded the nocturnal ISR maximum. In the latter part of the night of sleep deprivation and during the following morning, ISR declined while cortisol concentrations rose. Fig. 5 shows that the amplitudes of the diurnal variations of cortisol and ISR, when expressed as a percentage of the mean level, were positively correlated. Thus, the larger the cortisol drop from morning acrophase to evening nadir, the higher the ISR rise from morning nadir to nocturnal acrophase. This correlation between diurnal amplitudes of ISR and cortisol was found both during conditions of normal sleep (r = 0.67, P = 0.07, n = 8) and during sleep deprivation (r = 0.62, P < 0.10, n = 8) and was statistically significant when both conditions were considered together (r = 0.67, P < 0.005, n = 16). Correlations between amplitude of the diurnal glucose variations and amplitude of the cortisol rhythm were not significant (r = 0.25, P > 0.30, n = 16).
The increases in glucose and ISR after sleep onset did not correlate with changes in cortisol levels for either nocturnal or r 0.67, p 0.000 daytime sleep. However, during nocturnal sleep, the absolute increase in glucose levels was strongly correlated with the amount of GH secreted between 2200 and 0200 (r = 0.84, P < 0.01, n = 8; Fig. 6 ). A similar positive association between the magnitude of the glucose elevation during sleep and the amount ofGH secreted was observed during daytime sleep but failed to reach statistical significance (r = 0.56, P = 0.15, n = 8, Fig. 6 ). When nocturnal and daytime sleep were considered together, the coefficient of correlation between sleep-related glucose elevation and amount of GH secreted was 0.73 (P < 0.002, n = 16, Fig. 6 ). Correlations between sleep-related increases in ISR levels and amount of GH secreted failed to reach significance.
Discussion
In this study, glucose levels and insulin secretion were continuously monitored during constant glucose infusion for a total of 53 h, including an 8-h period of nocturnal sleep, a 28-h period of sleep deprivation, and an 8-h period of daytime sleep. effects of sleep could be observed at an abnormal circadian time, i.e., a time when sleep does not normally occur. To optimize interindividual synchronization, the subjects complied with a standardized schedule of sleep for one week before the study. An extended period of habituation served to minimize possible stress effects of hospitalization, laboratory procedures, and novel social environment. Confounding effects of food ingestion and prolonged fasting were avoided by replacing the normal caloric intake by a constant glucose infusion, thereby creating a steady-state condition with levels of glucose and insulin secretion within the physiologic range. During wakefulness, the level of physical activity was minimal and essentially constant. Sleep onset and maintenance were polygraphically monitored.
The profiles of peripheral glucose and insulin concentrations and ofinsulin secretion rates observed under these experimental conditions confirmed and extended the findings of previous studies showing decreased glucose tolerance in the afternoon and evening as compared to the morning (1) (2) (3) (4) (5) . The decrease in glucose tolerance continued throughout the evening and early part of the habitual sleep period. Irrespective of the sleep or wake condition, glucose levels and insulin secretion rates returned spontaneously to basal morning values. The magnitude of the nocturnal rise in the absence of sleep averaged 17% for glucose and almost 50% for insulin secretion. This marked increase in insulin secretion was not associated with a significant nocturnal elevation of serum insulin concentrations. This finding indicates the existence ofa diurnal variation in insulin clearance, consisting ofa nocturnal increase concomitant and almost commensurate with the rise in insulin secretion. Direct, independent measurements ofinsulin clearance at different times of day will be needed to confirm this observation. Reduced sensitivity of peripheral tissues to insulin has been shown to be a major cause of decreased glucose tolerance in the evening as compared to the morning (4) but inappropriate low insulin secretion has been implicated as well (1, 2, 5) . In this study, the simultaneous measurement of plasma levels of insulin and C-peptide, and the subsequent derivation ofinsulin secretion rates based on individual kinetic parameters for Cpeptide clearance and metabolism, showed that the effects of decreased insulin sensitivity and insufficient insulin secretion are compounded by a marked acceleration of the disposal of secreted insulin.
The persistence ofthe diurnal variation ofglucose tolerance in the absence of sleep and in the face ofconstant environmental conditions, continuously low levels ofactivity, and constant caloric intake strongly suggests that this diurnal variation must be, at least partially, controlled by signals originating from a robust circadian pacemaker. In mammalian species, increasing evidence points at the existence of a single central pacemaker, located in the suprachiasmatic nuclei of the hypothalamus, as the mechanism responsible for circadian rhythmicity (21) . So far, hormonal signalling appears to be the primary pathway for the transmission ofcentrally generated circadian oscillations to peripheral organs. Modulatory effects of circadian rhythmicity on glucose control could be mediated by counterregulatory hormones. Current concepts of glucose counterregulation in humans are primarily based on extensive studies of hypoglycemia, where abnormally low glucose levels are associated with increased secretion ofepinephrine, glucagon, growth hormone, and cortisol. Recent studies have also shown that prolonged fasting is associated with large increases in both GH and corti- (6, 15) . This study demonstrated that sleep onset, irrespective of the time ofday when it occurs, has profound effects on glucose regulation. Indeed, sleep onset resulted in a 10-20% elevation ofplasma glucose, a 50-60% increase in insulin secretion rates, and a 35-45% rise in serum insulin. Significant effects of sleep onset on insulin clearance could not be demonstrated. The effects ofsleep onset per se tended to be more pronounced after daytime sleep after 28 h of continuous wakefulness than when sleep occurred at the usual bedtime after a normal 16-h period ofdaytime wakefulness. As expected, sleep onset was also associated with a large pulse ofGH secretion. After nocturnal sleep, the absolute rise in glucose levels was strongly correlated with the amount of GH secretion and cortisol levels were not affected by sleep onset. After daytime sleep, there was a weaker association between the magnitude of the glucose rise and the amount of GH secreted and, in accordance with classical findings (25) , cortisol levels abruptly declined by 50%.
Little is known about the set-point of glucose regulation during sleep. Normal subjects studied during an overnight fast generally show stable or slightly declining levels ofglucose and insulin (26) (27) (28) . However, we are unaware of a single study where the onset and maintenance ofsleep were polygraphically monitored and where the experimental conditions allowed for continuous blood sampling for the measurement of glucose, insulin, and counterregulatory hormone levels without disturbing or interrupting the subject's sleep. Thus, while the differences in the nocturnal patterns ofglucose and insulin seen in this study and those seen during overnight fasting are likely to reflect primarily the effects of constant glucose infusion versus prolonged fasting, it must be recognized that, during normal overnight fasting, patterns ofglucose tolerance in the presence of sleep and of sleep-related changes in counterregulatory hormones have not yet been defined. In a recent study, Clore et al. (28) have reported that, in normal fasted men kept awake throughout the night while at bed rest, both glucose production and glucose utilization decrease by 14% on average, while in subjects who are permitted to sleep, these decreases were 20-30%. This study thus indicated the existence of a reduction of both glucose production and glucose utilization during sleep (28) . The size of the reduction in glucose utilization, i.e., 10%, is consistent with the reduction in muscular activity during sleep. In our study, however, the rises in glucose levels observed during daytime sleep, i.e., in the absence of superimposed effects of circadian rhythmicity, were well in excess of 10% and should thus involve either larger decreases in glucose utilization or increased hepatic glucose output. It is now established that physiological elevations of GH levels can cause a rapid decrease in glucose-induced glucose uptake and simultaneously augment endogenous glucose production (29, 30). Pulsatile administration of bovine GH in dogs induces a rapid increase in hepatic glucose output (31) . The correlations between the magnitude of the sleep-associated glucose rise and the concomitant amount of GH secretion seen in this study suggest that the effects of sleep on glucose tolerance may be partially mediated by the increase in GH secretion associated with sleep onset. Further studies will be necessary to delineate the respective roles of glucose production and glucose utilization in the sleep-associated changes in the set point of glucose regulation.
In conclusion, our study has demonstrated that both circadian rhythmicity and sleep are important physiological regulators ofglucose tolerance in normal man. These findings suggest that time of day may be important for the diagnosis and treatment of conditions of impaired glucose tolerance.
